ARCHIVES

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Biostatistician Calls For Reanalysis Of Canadian Breast Screening Study

February 10, 1995

In Brief: Peter Pisters named CEO of University Health Network in Toronto

August 8, 2014

Foundation Gives $1 Million To UPCI For Genetics Chair

December 13, 2002

As MD Anderson Targets Eight Cancers, Detailed War Plan Remains Under Wraps

September 21, 2012

No Justification Provided: AAUP Demands Reinstatement of Faculty Denied Tenure Renewal at MD Anderson

May 16, 2014

Emory Cancer Experiment Launched Into Space

January 17, 2003